OpenVSafe by OpenVAERS
Search V-safe

EY4-31517-16605

2 vaccinations 9 coded responses 21 check-ins 9 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
923 / CA
Registered
2020-12-18
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Fair · Headache
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  5. 2020-12-19
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  10. 2021-01-01
    Survey response — day 14, dose 1
    MedDRA: Nausea — Feeling: Fair
    Free text: I have felt nauseous for a couple of days, but better as of yesterday afternoon. Was nauseous for two days.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-05
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nausea — Feeling: Fair · Site: Pain · Nausea
    Free text: I have been nauseous since the first injection that is worse at night
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  14. 2021-01-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite — Feeling: Fair · Nausea · Be unable to do your normal daily activities
    Free text: I have experienced a decrease at times in eating. Not a truly bad issue since it helps with reaching my weight loss goal
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-08
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  16. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Nausea, Office visit — Feeling: Good · Nausea
    Free text: I just completed a salt cave session that was very beneficial to my nausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-12
    Health check-in — day 7, dose 2
    Feeling: Fair · None
    Adult check-in
  19. 2021-01-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-01-26
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-04
    Survey response — day 28, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to work
    Free text: Tired more often.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-16
    Survey response — day 42, dose 2
    MedDRA: Fatigue, Nausea, Pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue, slight body aches, and nausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-04-06
    Survey response — 3 months, dose 2
    MedDRA: Fatigue, Hypersensitivity, Pre-existing disease — Feeling: Fair
    Free text: My allergies have increased and I more tired.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-07-06
    Survey response — 6 months, dose 2
    MedDRA: Cough — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Ongoing cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2022-01-05
    Survey response — 12 months, dose 2
    MedDRA: Hypersensitivity, Pre-existing disease — Feeling: Fair
    Free text: Allergy sxs have increased
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-05Pfizer-BioNTech

Call center

2 call center cases

2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-01

Symptoms: I have felt nauseous for a couple of days, but better as of yesterday afternoon. Was nauseous for two days.

Release 1 — days 1–6 daily, dose 2

2021-01-06

Systemic reaction (other): I have been nauseous since the first injection that is worse at night

2021-01-08

Systemic reaction (other): I have experienced a decrease at times in eating. Not a truly bad issue since it helps with reaching my weight loss goal

2021-01-09

Systemic reaction (other): I just completed a salt cave session that was very beneficial to my nausea

Release 3 — day 28, dose 2

2021-02-04

Symptoms: Tired more often.

Release 4 — day 42, dose 2

2021-02-16

Symptoms: Fatigue, slight body aches, and nausea

Release 7 — 3 months, dose 2

2021-04-06

Symptoms: My allergies have increased and I more tired.

Release 9 — 6 months, dose 2

2021-07-06

Symptoms: Ongoing cough

Release 10 — 12 months, dose 2

2022-01-05

Symptoms: Allergy sxs have increased

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHypersensitivity ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPre-existing disease ✓ · ✓
SRODecreased appetite ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SROOffice visit ✓ ✓ ✓
SROSalt craving ○ ○ ○

✓ active code · ○ coded but marked inactive · blank = not in that release